Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Results ACPs can be used directly as cytotoxic agents (molecularly targeted peptides) or can act as carriers (guiding missile) of chemotherapeutic agents and radionuclides by specifically targeting cancer cells
It was shown that targeting Nedd4-2 would promote cellular EnaC expression and exacerbate Liddle syndrome[64]
(2018) 141:e20171811
Most current therapeutic candidates for NDDs face challenges in crossing the bloodbrain barrier, substantially limiting their clinical efficacy (Ross and Poirier, 2004)
The peptide could be degraded, the water could be contaminated, or the vial temperature may have caused precipitation
US$ 25.07
&srotate=0)
US$ 22.58
/assets/docs/446094.jpg)
US$ 28.61
US$ 29.36
US$ 24.21
US$ 25.58
US$ 28.50
US$ 26.08
US$ 21.14
